EVMN
Evommune·NYSE
--
--(--)
--
--(--)
4.99 / 10
Netural
Fund flow evaluation: 7.66/10 reflecting robust fund flow characteristics. Constructive overall, block, Small, Medium, Large, and Extra-large trends face headwinds from adverse no significant trends developments, indicating positive money flow direction. Research analyst consensus shows overwhelmingly bullish analyst consensus, demonstrating strong conviction. Current ratings: Strong Buy(66.7%), Buy(33.3%) across 3 coverage providers, supported by 2.31 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-22
InstitutionOppenheimer
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of EVMN?
- EVMN holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.99/10 (Netural).
